Suggested Topics within your search.
Suggested Topics within your search.
- Neoplasms 10
- drug therapy
- therapeutic use
- therapy 10
- complications 7
- Analgesics, Opioid 3
- Angiogenesis Inhibitors 3
- Antineoplastic Agents 3
- Carcinoma, Non-Small-Cell Lung 3
- Clinical Trials, Phase I as Topic 3
- Lung Neoplasms 3
- Pain 3
- prevention & control 3
- Methyltransferases 1
- Pharmacogenetics 1
- genetics 1
-
1
Genetic polymorphism of thiopurine methyltransferase and thiopurine therapy from molecular genetics to clinical medicine /
Published 2009Subjects: Get full text
Series
Electronic Video -
2
Phase I study design for non-cytotoxic agents
Published 2009Subjects: Get full text
Series
Electronic Video -
3
The rational use of opioid analgesics for cancer pain with a critique of the WHO 3-step ladder /
Published 2009Subjects: Get full text
Series
Electronic Video -
4
Bevacizumab the first FDA-approved angiogenesis inhibitor in the treatment of non-small cell lung cancer /
Published 2009Subjects: Get full text
Series
Electronic Video -
5
Phase I study design for non-cytotoxic agents
Published 2009Subjects: Get full text
Series
Electronic Video -
6
Phase I study design for non-cytotoxic agents
Published 2009Subjects: Get full text
Series
Electronic Video -
7
The rational use of opioid analgesics for cancer pain with a critique of the WHO 3-step ladder /
Published 2009Subjects: Get full text
Series
Electronic Video -
8
The rational use of opioid analgesics for cancer pain with a critique of the WHO 3-step ladder /
Published 2009Subjects: Get full text
Series
Electronic Video -
9
Bevacizumab the first FDA-approved angiogenesis inhibitor in the treatment of non-small cell lung cancer /
Published 2009Subjects: Get full text
Series
Electronic Video -
10
Bevacizumab the first FDA-approved angiogenesis inhibitor in the treatment of non-small cell lung cancer /
Published 2009Subjects: Get full text
Series
Electronic Video